We are proud to be recognized by U.S. News and World’s reports’ 2013 to 2014 best hospitals in America. Cardiology and Heart Surgery were two of eight high performing specialties to be recognized at Intermountain Medical Center. The report also ranked Intermountain Medical Center as the number one hospital in Utah.
Becker’s Hospital Review has listed Intermountain Medical Center as tied for the lowest (best) 30-day readmission rate for heart attack patients in the nation. The published list, “50 hospitals with the lowest 30-day readmission rates for heart attack patients" was published in July of 2013.
Intermountain Heart Institute is also one of Becker's 100 Hospitals with Great Heart Programs. These hospitals have made strides to combat heart disease through innovative clinical research, high-quality care and state-of-the-art treatments. These hospitals have also educated their local communities about heart health, helping sharpen our country's focus on preventive care and population health.
Intermountain Heart Institute is a 5-time winner of Thomsen Reuter's (Solucient's) healthcare awards: 100 Top Hospitals with Cardiovascular Residency Programs.
Our imaging programs follow standards that are globally practiced and accredited by the Intersocietal Accreditation Commission (IAC). Our echo lab has achieved IACEL accreditation for the last 9 years.
Intermountain Heart Institute is certified at the highest level by the American Association of Cardiovascular and Pulmonary Rehabilitation, a national organization with rigorous standards and requirements for cardiac rehabilitation programs.
Our hospital holds the American Heart Association's "Get With The Guidelines Heart Failure Gold Award" for delivering excellent, evidence-based care for heart failure patients.
Our Heart Failure and Transplant Program holds disease-specific certification from the Joint Commission in Advanced Heart Failure. (July 2011).
Destination Therapy – Left Ventricular Assist Devices
Our Artificial Heart Program is certified by the Joint Commission and CMS to implant left ventricular assist devices in patients who will rely on them for the remainder of their lives.